All terms in BMONT

Label Id Description
nighttime rest measurement EFO_0007827 [quantification of some aspect of nighttime rest such as duration or quality]
Chronic Liver Disease NCIT_C113609 [Hepatic necrosis, inflammation, or scarring due to any cause that persists for more than 6 months. Manifestations may include signs and symptoms of cholestasis, portal hypertension, and/or abnormal liver function tests.]
liver disease DOID_409
statistical hypothesis test OBI_0000673 [A statistical hypothesis test data transformation is a data transformation that has objective statistical hypothesis test.]
statistical analysis GSSO_012786 [Analyses regarding statistical data.]
calcium metabolic disease EFO_0005769 [Disorders of calcium metabolism occur when the body has too little or too much calcium. The serum level of calcium is closely regulated within a fairly limited range in the human body. In a healthy physiology, extracellular calcium levels are maintained within a tight range through the actions of parathyroid hormone, vitamin D and the calcium sensing receptor.[1] Disorders in calcium metabolism can lead to hypocalcemia, decreased plasma levels of calcium or hypercalcemia, elevated plasma calcium levels., Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.]
ejection fraction measurement EFO_0005527 [quantification of the volumetric fraction of blood pumped out of the left and right ventricle with each heartbeat or cardiac cycle]
RNA biomarker OPMI_0000459 [A molecular biomarker at the RNA level, Oliver He, Yingtong Liu]
molecular biomarker OPMI_0000452
diagnostic biomarker OPMI_0000457 [A biomarker that can serve a role in narrowing down diagnosis, which can lead to diagnosis that is significantly more specific to individual patients.]
DNA biomarker OPMI_0000458 [A molecular biomarker at the DNA gene level, Oliver He, Yingtong Liu]
predictive biomarker OPMI_0000455 [A biomarker that can predict clincal outcome.]
prognostic biomarker OPMI_0000456 [A biomarker that provides information about the patient's overall outcome, regardless of therapy.]
cellular biomarker OPMI_0000453 [Cellular biomarkers are marked cells that can be isolated, sorted, quantified and characterized by their morphology and physiology, and used in both clinical and laboratory settings for different biomarker applications. An example of a cellular biomarker sorting technique is Fluorescent-activated cell sorting.]
imaging biomarker OPMI_0000454
cisplatin CHEBI_27899 [A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary. Commonly but incorrectly described as an alkylating agent due to its mechanism of action (but it lacks alkyl groups).]
cortical thinning BMONT_0000167 [Cortical thinning is the gradual reduction in the thickness of the brain’s cerebral cortex—the outer layer of neural tissue involved in functions such as perception, memory, and decision-making. It is commonly measured using neuroimaging techniques like MRI and is associated with normal aging, neurodegenerative diseases (e.g., Alzheimer’s), and certain psychiatric conditions.]
pathologic process OBI_1110122 [abnormal, harmful processes caused by or associated with a disease]
functional connectivity decline BMONT_0000168 [Functional connectivity decline refers to a reduction in the coordinated activity or communication between different regions of the brain over time. It typically indicates weakened synchronization in neural signals, often observed in aging, neurodegenerative diseases (like Alzheimer’s), or brain injury. This decline can affect cognitive functions such as memory, attention, and executive processing.]
blood plasma UBERON_0001969 [The liquid component of blood, in which erythrocytes are suspended.]